Cargando…
Anti-Sars-Cov-2 Antibody and T-Cell Responses Using Deep T-Cell Receptor Immunosequencing after Vaccination Among Healthy Individuals and Patients with Multiple Myeloma or Lymphoma
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665221/ http://dx.doi.org/10.1182/blood-2022-158721 |
| _version_ | 1784831242787618816 |
|---|---|
| author | Takamatsu, Hiroyuki Ikeda, Daisuke Terao, Toshiki Yamashita, Takeshi Urushihara, Ryota Hatano, Yuzuki Hirose, Nana Yamada, Natsu Murata, Ryoichi Miyamoto, Toshihiro Matsue, Kosei |
| author_facet | Takamatsu, Hiroyuki Ikeda, Daisuke Terao, Toshiki Yamashita, Takeshi Urushihara, Ryota Hatano, Yuzuki Hirose, Nana Yamada, Natsu Murata, Ryoichi Miyamoto, Toshihiro Matsue, Kosei |
| author_sort | Takamatsu, Hiroyuki |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9665221 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The American Society of Hematology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96652212022-11-16 Anti-Sars-Cov-2 Antibody and T-Cell Responses Using Deep T-Cell Receptor Immunosequencing after Vaccination Among Healthy Individuals and Patients with Multiple Myeloma or Lymphoma Takamatsu, Hiroyuki Ikeda, Daisuke Terao, Toshiki Yamashita, Takeshi Urushihara, Ryota Hatano, Yuzuki Hirose, Nana Yamada, Natsu Murata, Ryoichi Miyamoto, Toshihiro Matsue, Kosei Blood Oral Abstracts The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9665221/ http://dx.doi.org/10.1182/blood-2022-158721 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Oral Abstracts Takamatsu, Hiroyuki Ikeda, Daisuke Terao, Toshiki Yamashita, Takeshi Urushihara, Ryota Hatano, Yuzuki Hirose, Nana Yamada, Natsu Murata, Ryoichi Miyamoto, Toshihiro Matsue, Kosei Anti-Sars-Cov-2 Antibody and T-Cell Responses Using Deep T-Cell Receptor Immunosequencing after Vaccination Among Healthy Individuals and Patients with Multiple Myeloma or Lymphoma |
| title | Anti-Sars-Cov-2 Antibody and T-Cell Responses Using Deep T-Cell Receptor Immunosequencing after Vaccination Among Healthy Individuals and Patients with Multiple Myeloma or Lymphoma |
| title_full | Anti-Sars-Cov-2 Antibody and T-Cell Responses Using Deep T-Cell Receptor Immunosequencing after Vaccination Among Healthy Individuals and Patients with Multiple Myeloma or Lymphoma |
| title_fullStr | Anti-Sars-Cov-2 Antibody and T-Cell Responses Using Deep T-Cell Receptor Immunosequencing after Vaccination Among Healthy Individuals and Patients with Multiple Myeloma or Lymphoma |
| title_full_unstemmed | Anti-Sars-Cov-2 Antibody and T-Cell Responses Using Deep T-Cell Receptor Immunosequencing after Vaccination Among Healthy Individuals and Patients with Multiple Myeloma or Lymphoma |
| title_short | Anti-Sars-Cov-2 Antibody and T-Cell Responses Using Deep T-Cell Receptor Immunosequencing after Vaccination Among Healthy Individuals and Patients with Multiple Myeloma or Lymphoma |
| title_sort | anti-sars-cov-2 antibody and t-cell responses using deep t-cell receptor immunosequencing after vaccination among healthy individuals and patients with multiple myeloma or lymphoma |
| topic | Oral Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665221/ http://dx.doi.org/10.1182/blood-2022-158721 |
| work_keys_str_mv | AT takamatsuhiroyuki antisarscov2antibodyandtcellresponsesusingdeeptcellreceptorimmunosequencingaftervaccinationamonghealthyindividualsandpatientswithmultiplemyelomaorlymphoma AT ikedadaisuke antisarscov2antibodyandtcellresponsesusingdeeptcellreceptorimmunosequencingaftervaccinationamonghealthyindividualsandpatientswithmultiplemyelomaorlymphoma AT teraotoshiki antisarscov2antibodyandtcellresponsesusingdeeptcellreceptorimmunosequencingaftervaccinationamonghealthyindividualsandpatientswithmultiplemyelomaorlymphoma AT yamashitatakeshi antisarscov2antibodyandtcellresponsesusingdeeptcellreceptorimmunosequencingaftervaccinationamonghealthyindividualsandpatientswithmultiplemyelomaorlymphoma AT urushihararyota antisarscov2antibodyandtcellresponsesusingdeeptcellreceptorimmunosequencingaftervaccinationamonghealthyindividualsandpatientswithmultiplemyelomaorlymphoma AT hatanoyuzuki antisarscov2antibodyandtcellresponsesusingdeeptcellreceptorimmunosequencingaftervaccinationamonghealthyindividualsandpatientswithmultiplemyelomaorlymphoma AT hirosenana antisarscov2antibodyandtcellresponsesusingdeeptcellreceptorimmunosequencingaftervaccinationamonghealthyindividualsandpatientswithmultiplemyelomaorlymphoma AT yamadanatsu antisarscov2antibodyandtcellresponsesusingdeeptcellreceptorimmunosequencingaftervaccinationamonghealthyindividualsandpatientswithmultiplemyelomaorlymphoma AT murataryoichi antisarscov2antibodyandtcellresponsesusingdeeptcellreceptorimmunosequencingaftervaccinationamonghealthyindividualsandpatientswithmultiplemyelomaorlymphoma AT miyamototoshihiro antisarscov2antibodyandtcellresponsesusingdeeptcellreceptorimmunosequencingaftervaccinationamonghealthyindividualsandpatientswithmultiplemyelomaorlymphoma AT matsuekosei antisarscov2antibodyandtcellresponsesusingdeeptcellreceptorimmunosequencingaftervaccinationamonghealthyindividualsandpatientswithmultiplemyelomaorlymphoma |